nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP2C8—Spironolactone—dilated cardiomyopathy	0.194	1	CbGbCtD
Oxybutynin—Depressive symptom—Lisinopril—dilated cardiomyopathy	0.0289	0.0424	CcSEcCtD
Oxybutynin—Hexylcaine—SCN5A—dilated cardiomyopathy	0.0287	1	CrCbGaD
Oxybutynin—Application site pain—Furosemide—dilated cardiomyopathy	0.0191	0.0281	CcSEcCtD
Oxybutynin—Flank pain—Lisinopril—dilated cardiomyopathy	0.0157	0.023	CcSEcCtD
Oxybutynin—Generalised oedema—Lisinopril—dilated cardiomyopathy	0.0106	0.0156	CcSEcCtD
Oxybutynin—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00894	0.0131	CcSEcCtD
Oxybutynin—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00865	0.0127	CcSEcCtD
Oxybutynin—Memory impairment—Lisinopril—dilated cardiomyopathy	0.00804	0.0118	CcSEcCtD
Oxybutynin—Bladder pain—Furosemide—dilated cardiomyopathy	0.00761	0.0112	CcSEcCtD
Oxybutynin—Mental disability—Furosemide—dilated cardiomyopathy	0.0073	0.0107	CcSEcCtD
Oxybutynin—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00713	0.0105	CcSEcCtD
Oxybutynin—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00713	0.0105	CcSEcCtD
Oxybutynin—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00694	0.0102	CcSEcCtD
Oxybutynin—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00694	0.0102	CcSEcCtD
Oxybutynin—Cough increased—Lisinopril—dilated cardiomyopathy	0.0069	0.0101	CcSEcCtD
Oxybutynin—Creatinine increased—Lisinopril—dilated cardiomyopathy	0.00663	0.00973	CcSEcCtD
Oxybutynin—Thirst—Furosemide—dilated cardiomyopathy	0.00642	0.00941	CcSEcCtD
Oxybutynin—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00639	0.00937	CcSEcCtD
Oxybutynin—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00627	0.0092	CcSEcCtD
Oxybutynin—Cystitis noninfective—Lisinopril—dilated cardiomyopathy	0.00617	0.00904	CcSEcCtD
Oxybutynin—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00613	0.00899	CcSEcCtD
Oxybutynin—Malaise—Spironolactone—dilated cardiomyopathy	0.0061	0.00894	CcSEcCtD
Oxybutynin—Cystitis—Lisinopril—dilated cardiomyopathy	0.0061	0.00894	CcSEcCtD
Oxybutynin—Fluid retention—Lisinopril—dilated cardiomyopathy	0.00599	0.00879	CcSEcCtD
Oxybutynin—Urinary retention—Furosemide—dilated cardiomyopathy	0.00581	0.00852	CcSEcCtD
Oxybutynin—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00572	0.00839	CcSEcCtD
Oxybutynin—Bladder pain—Lisinopril—dilated cardiomyopathy	0.00571	0.00837	CcSEcCtD
Oxybutynin—Discomfort—Spironolactone—dilated cardiomyopathy	0.00569	0.00834	CcSEcCtD
Oxybutynin—Confusional state—Spironolactone—dilated cardiomyopathy	0.00556	0.00816	CcSEcCtD
Oxybutynin—Hypertonia—Lisinopril—dilated cardiomyopathy	0.00553	0.00812	CcSEcCtD
Oxybutynin—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00552	0.00809	CcSEcCtD
Oxybutynin—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00531	0.00779	CcSEcCtD
Oxybutynin—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00529	0.00776	CcSEcCtD
Oxybutynin—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00503	0.00738	CcSEcCtD
Oxybutynin—Injury—Lisinopril—dilated cardiomyopathy	0.00499	0.00731	CcSEcCtD
Oxybutynin—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00494	0.00725	CcSEcCtD
Oxybutynin—Somnolence—Spironolactone—dilated cardiomyopathy	0.0049	0.00719	CcSEcCtD
Oxybutynin—Pollakiuria—Furosemide—dilated cardiomyopathy	0.00488	0.00715	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00476	0.00699	CcSEcCtD
Oxybutynin—Arthritis—Lisinopril—dilated cardiomyopathy	0.00471	0.00692	CcSEcCtD
Oxybutynin—Drowsiness—Furosemide—dilated cardiomyopathy	0.00471	0.0069	CcSEcCtD
Oxybutynin—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00458	0.00672	CcSEcCtD
Oxybutynin—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00458	0.00672	CcSEcCtD
Oxybutynin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00455	0.00667	CcSEcCtD
Oxybutynin—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00455	0.00667	CcSEcCtD
Oxybutynin—Face oedema—Lisinopril—dilated cardiomyopathy	0.00442	0.00649	CcSEcCtD
Oxybutynin—Urticaria—Spironolactone—dilated cardiomyopathy	0.00438	0.00643	CcSEcCtD
Oxybutynin—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00429	0.0063	CcSEcCtD
Oxybutynin—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00417	0.00612	CcSEcCtD
Oxybutynin—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00414	0.00608	CcSEcCtD
Oxybutynin—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00414	0.00607	CcSEcCtD
Oxybutynin—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.0041	0.00601	CcSEcCtD
Oxybutynin—Visual impairment—Furosemide—dilated cardiomyopathy	0.00407	0.00597	CcSEcCtD
Oxybutynin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00406	0.00596	CcSEcCtD
Oxybutynin—Asthma—Lisinopril—dilated cardiomyopathy	0.00396	0.00581	CcSEcCtD
Oxybutynin—Influenza—Lisinopril—dilated cardiomyopathy	0.00396	0.00581	CcSEcCtD
Oxybutynin—Eye disorder—Furosemide—dilated cardiomyopathy	0.00395	0.00579	CcSEcCtD
Oxybutynin—Tinnitus—Furosemide—dilated cardiomyopathy	0.00394	0.00578	CcSEcCtD
Oxybutynin—Pruritus—Spironolactone—dilated cardiomyopathy	0.0039	0.00573	CcSEcCtD
Oxybutynin—Angiopathy—Furosemide—dilated cardiomyopathy	0.00383	0.00562	CcSEcCtD
Oxybutynin—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00381	0.00559	CcSEcCtD
Oxybutynin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00377	0.00554	CcSEcCtD
Oxybutynin—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00377	0.00554	CcSEcCtD
Oxybutynin—Dysuria—Lisinopril—dilated cardiomyopathy	0.0037	0.00543	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00368	0.0054	CcSEcCtD
Oxybutynin—Erythema—Furosemide—dilated cardiomyopathy	0.00368	0.00539	CcSEcCtD
Oxybutynin—Malnutrition—Furosemide—dilated cardiomyopathy	0.00368	0.00539	CcSEcCtD
Oxybutynin—Dizziness—Spironolactone—dilated cardiomyopathy	0.00365	0.00535	CcSEcCtD
Oxybutynin—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00365	0.00535	CcSEcCtD
Oxybutynin—Flatulence—Furosemide—dilated cardiomyopathy	0.00362	0.00532	CcSEcCtD
Oxybutynin—Dysgeusia—Furosemide—dilated cardiomyopathy	0.0036	0.00528	CcSEcCtD
Oxybutynin—Depression—Lisinopril—dilated cardiomyopathy	0.00352	0.00516	CcSEcCtD
Oxybutynin—Vomiting—Spironolactone—dilated cardiomyopathy	0.00351	0.00515	CcSEcCtD
Oxybutynin—Rash—Spironolactone—dilated cardiomyopathy	0.00348	0.0051	CcSEcCtD
Oxybutynin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00348	0.0051	CcSEcCtD
Oxybutynin—Vision blurred—Furosemide—dilated cardiomyopathy	0.00347	0.00508	CcSEcCtD
Oxybutynin—Headache—Spironolactone—dilated cardiomyopathy	0.00346	0.00507	CcSEcCtD
Oxybutynin—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00343	0.00503	CcSEcCtD
Oxybutynin—Agitation—Furosemide—dilated cardiomyopathy	0.00338	0.00496	CcSEcCtD
Oxybutynin—Haematuria—Lisinopril—dilated cardiomyopathy	0.00337	0.00494	CcSEcCtD
Oxybutynin—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00333	0.00489	CcSEcCtD
Oxybutynin—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00331	0.00486	CcSEcCtD
Oxybutynin—Nausea—Spironolactone—dilated cardiomyopathy	0.00328	0.00481	CcSEcCtD
Oxybutynin—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00318	0.00466	CcSEcCtD
Oxybutynin—Hallucination—Lisinopril—dilated cardiomyopathy	0.00315	0.00463	CcSEcCtD
Oxybutynin—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00315	0.00462	CcSEcCtD
Oxybutynin—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00313	0.00459	CcSEcCtD
Oxybutynin—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00312	0.00458	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00311	0.00456	CcSEcCtD
Oxybutynin—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00311	0.00456	CcSEcCtD
Oxybutynin—Dry mouth—Furosemide—dilated cardiomyopathy	0.00306	0.00449	CcSEcCtD
Oxybutynin—Confusional state—Furosemide—dilated cardiomyopathy	0.00303	0.00444	CcSEcCtD
Oxybutynin—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.003	0.0044	CcSEcCtD
Oxybutynin—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00296	0.00434	CcSEcCtD
Oxybutynin—Shock—Furosemide—dilated cardiomyopathy	0.00295	0.00433	CcSEcCtD
Oxybutynin—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00294	0.00432	CcSEcCtD
Oxybutynin—Flushing—Lisinopril—dilated cardiomyopathy	0.00294	0.00432	CcSEcCtD
Oxybutynin—Skin disorder—Furosemide—dilated cardiomyopathy	0.00292	0.00428	CcSEcCtD
Oxybutynin—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00288	0.00422	CcSEcCtD
Oxybutynin—Anorexia—Furosemide—dilated cardiomyopathy	0.00286	0.0042	CcSEcCtD
Oxybutynin—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00286	0.00419	CcSEcCtD
Oxybutynin—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00283	0.00415	CcSEcCtD
Oxybutynin—Hypotension—Furosemide—dilated cardiomyopathy	0.0028	0.00411	CcSEcCtD
Oxybutynin—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00278	0.00407	CcSEcCtD
Oxybutynin—Erythema—Lisinopril—dilated cardiomyopathy	0.00276	0.00405	CcSEcCtD
Oxybutynin—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00276	0.00405	CcSEcCtD
Oxybutynin—Flatulence—Lisinopril—dilated cardiomyopathy	0.00272	0.00399	CcSEcCtD
Oxybutynin—Tension—Lisinopril—dilated cardiomyopathy	0.00271	0.00397	CcSEcCtD
Oxybutynin—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.0027	0.00396	CcSEcCtD
Oxybutynin—Paraesthesia—Furosemide—dilated cardiomyopathy	0.0027	0.00395	CcSEcCtD
Oxybutynin—Nervousness—Lisinopril—dilated cardiomyopathy	0.00268	0.00393	CcSEcCtD
Oxybutynin—Back pain—Lisinopril—dilated cardiomyopathy	0.00267	0.00392	CcSEcCtD
Oxybutynin—Somnolence—Furosemide—dilated cardiomyopathy	0.00267	0.00391	CcSEcCtD
Oxybutynin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00261	0.00383	CcSEcCtD
Oxybutynin—Vision blurred—Lisinopril—dilated cardiomyopathy	0.0026	0.00381	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00259	0.0038	CcSEcCtD
Oxybutynin—Fatigue—Furosemide—dilated cardiomyopathy	0.00259	0.0038	CcSEcCtD
Oxybutynin—Pain—Furosemide—dilated cardiomyopathy	0.00257	0.00377	CcSEcCtD
Oxybutynin—Constipation—Furosemide—dilated cardiomyopathy	0.00257	0.00377	CcSEcCtD
Oxybutynin—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00256	0.00376	CcSEcCtD
Oxybutynin—Angioedema—Lisinopril—dilated cardiomyopathy	0.00252	0.0037	CcSEcCtD
Oxybutynin—Malaise—Lisinopril—dilated cardiomyopathy	0.00249	0.00365	CcSEcCtD
Oxybutynin—Syncope—Lisinopril—dilated cardiomyopathy	0.00247	0.00363	CcSEcCtD
Oxybutynin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00247	0.00363	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00245	0.0036	CcSEcCtD
Oxybutynin—Palpitations—Lisinopril—dilated cardiomyopathy	0.00244	0.00358	CcSEcCtD
Oxybutynin—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00243	0.00356	CcSEcCtD
Oxybutynin—Cough—Lisinopril—dilated cardiomyopathy	0.00241	0.00353	CcSEcCtD
Oxybutynin—Urticaria—Furosemide—dilated cardiomyopathy	0.00238	0.0035	CcSEcCtD
Oxybutynin—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00237	0.00348	CcSEcCtD
Oxybutynin—Chest pain—Lisinopril—dilated cardiomyopathy	0.00235	0.00345	CcSEcCtD
Oxybutynin—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00235	0.00345	CcSEcCtD
Oxybutynin—Anxiety—Lisinopril—dilated cardiomyopathy	0.00234	0.00343	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00233	0.00342	CcSEcCtD
Oxybutynin—Discomfort—Lisinopril—dilated cardiomyopathy	0.00232	0.0034	CcSEcCtD
Oxybutynin—Dry mouth—Lisinopril—dilated cardiomyopathy	0.0023	0.00337	CcSEcCtD
Oxybutynin—Confusional state—Lisinopril—dilated cardiomyopathy	0.00227	0.00333	CcSEcCtD
Oxybutynin—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00225	0.0033	CcSEcCtD
Oxybutynin—Oedema—Lisinopril—dilated cardiomyopathy	0.00225	0.0033	CcSEcCtD
Oxybutynin—Infection—Lisinopril—dilated cardiomyopathy	0.00224	0.00328	CcSEcCtD
Oxybutynin—Shock—Lisinopril—dilated cardiomyopathy	0.00222	0.00325	CcSEcCtD
Oxybutynin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00221	0.00324	CcSEcCtD
Oxybutynin—Tachycardia—Lisinopril—dilated cardiomyopathy	0.0022	0.00322	CcSEcCtD
Oxybutynin—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00219	0.00321	CcSEcCtD
Oxybutynin—Asthenia—Furosemide—dilated cardiomyopathy	0.00215	0.00316	CcSEcCtD
Oxybutynin—Anorexia—Lisinopril—dilated cardiomyopathy	0.00215	0.00315	CcSEcCtD
Oxybutynin—Pruritus—Furosemide—dilated cardiomyopathy	0.00212	0.00312	CcSEcCtD
Oxybutynin—Hypotension—Lisinopril—dilated cardiomyopathy	0.0021	0.00309	CcSEcCtD
Oxybutynin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00205	0.00301	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00205	0.00301	CcSEcCtD
Oxybutynin—Insomnia—Lisinopril—dilated cardiomyopathy	0.00204	0.00299	CcSEcCtD
Oxybutynin—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00202	0.00297	CcSEcCtD
Oxybutynin—Somnolence—Lisinopril—dilated cardiomyopathy	0.002	0.00294	CcSEcCtD
Oxybutynin—Dizziness—Furosemide—dilated cardiomyopathy	0.00198	0.00291	CcSEcCtD
Oxybutynin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00198	0.00291	CcSEcCtD
Oxybutynin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00196	0.00287	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00194	0.00285	CcSEcCtD
Oxybutynin—Fatigue—Lisinopril—dilated cardiomyopathy	0.00194	0.00285	CcSEcCtD
Oxybutynin—Pain—Lisinopril—dilated cardiomyopathy	0.00193	0.00283	CcSEcCtD
Oxybutynin—Constipation—Lisinopril—dilated cardiomyopathy	0.00193	0.00283	CcSEcCtD
Oxybutynin—Vomiting—Furosemide—dilated cardiomyopathy	0.00191	0.0028	CcSEcCtD
Oxybutynin—Rash—Furosemide—dilated cardiomyopathy	0.00189	0.00278	CcSEcCtD
Oxybutynin—Dermatitis—Furosemide—dilated cardiomyopathy	0.00189	0.00277	CcSEcCtD
Oxybutynin—Headache—Furosemide—dilated cardiomyopathy	0.00188	0.00276	CcSEcCtD
Oxybutynin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00186	0.00272	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00184	0.0027	CcSEcCtD
Oxybutynin—Urticaria—Lisinopril—dilated cardiomyopathy	0.00179	0.00262	CcSEcCtD
Oxybutynin—Nausea—Furosemide—dilated cardiomyopathy	0.00178	0.00262	CcSEcCtD
Oxybutynin—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00178	0.00261	CcSEcCtD
Oxybutynin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00166	0.00243	CcSEcCtD
Oxybutynin—Asthenia—Lisinopril—dilated cardiomyopathy	0.00162	0.00237	CcSEcCtD
Oxybutynin—Pruritus—Lisinopril—dilated cardiomyopathy	0.00159	0.00234	CcSEcCtD
Oxybutynin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00154	0.00226	CcSEcCtD
Oxybutynin—Dizziness—Lisinopril—dilated cardiomyopathy	0.00149	0.00218	CcSEcCtD
Oxybutynin—Vomiting—Lisinopril—dilated cardiomyopathy	0.00143	0.0021	CcSEcCtD
Oxybutynin—Rash—Lisinopril—dilated cardiomyopathy	0.00142	0.00208	CcSEcCtD
Oxybutynin—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00142	0.00208	CcSEcCtD
Oxybutynin—Headache—Lisinopril—dilated cardiomyopathy	0.00141	0.00207	CcSEcCtD
Oxybutynin—Nausea—Lisinopril—dilated cardiomyopathy	0.00134	0.00196	CcSEcCtD
Oxybutynin—CHRM5—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000341	0.00356	CbGpPWpGaD
Oxybutynin—CHRM3—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00034	0.00355	CbGpPWpGaD
Oxybutynin—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.000339	0.00354	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000338	0.00353	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000332	0.00347	CbGpPWpGaD
Oxybutynin—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000326	0.00341	CbGpPWpGaD
Oxybutynin—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00032	0.00335	CbGpPWpGaD
Oxybutynin—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000318	0.00333	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000317	0.00332	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000317	0.00332	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000317	0.00332	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000314	0.00329	CbGpPWpGaD
Oxybutynin—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000308	0.00322	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000307	0.00321	CbGpPWpGaD
Oxybutynin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000305	0.00319	CbGpPWpGaD
Oxybutynin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000305	0.00318	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000304	0.00318	CbGpPWpGaD
Oxybutynin—CHRM5—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000304	0.00318	CbGpPWpGaD
Oxybutynin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.000304	0.00318	CbGpPWpGaD
Oxybutynin—CHRM1—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.000301	0.00315	CbGpPWpGaD
Oxybutynin—CHRM3—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.0003	0.00314	CbGpPWpGaD
Oxybutynin—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.000297	0.00311	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000295	0.00308	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000293	0.00307	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000293	0.00307	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000293	0.00306	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000293	0.00306	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00029	0.00303	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00029	0.00303	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000286	0.00299	CbGpPWpGaD
Oxybutynin—CHRM5—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000283	0.00296	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000273	0.00285	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000272	0.00284	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000269	0.00282	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000264	0.00276	CbGpPWpGaD
Oxybutynin—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000263	0.00275	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000263	0.00275	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000263	0.00274	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000261	0.00273	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00026	0.00272	CbGpPWpGaD
Oxybutynin—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00025	0.00261	CbGpPWpGaD
Oxybutynin—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000249	0.0026	CbGpPWpGaD
Oxybutynin—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000247	0.00258	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000244	0.00255	CbGpPWpGaD
Oxybutynin—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000242	0.00253	CbGpPWpGaD
Oxybutynin—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00024	0.00251	CbGpPWpGaD
Oxybutynin—CHRM3—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000239	0.0025	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000232	0.00242	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000226	0.00236	CbGpPWpGaD
Oxybutynin—CHRM5—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000226	0.00236	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000225	0.00235	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000223	0.00234	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000223	0.00234	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000223	0.00233	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000223	0.00233	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000223	0.00233	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000221	0.00231	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000221	0.00231	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—ANKRD1—dilated cardiomyopathy	0.000216	0.00226	CbGpPWpGaD
Oxybutynin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000214	0.00224	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000214	0.00224	CbGpPWpGaD
Oxybutynin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000214	0.00223	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000213	0.00223	CbGpPWpGaD
Oxybutynin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000211	0.00221	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000211	0.00221	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000208	0.00217	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000207	0.00216	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000205	0.00214	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—TAZ—dilated cardiomyopathy	0.000203	0.00212	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000201	0.0021	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000201	0.0021	CbGpPWpGaD
Oxybutynin—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.0002	0.00209	CbGpPWpGaD
Oxybutynin—CHRM3—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000199	0.00208	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000199	0.00208	CbGpPWpGaD
Oxybutynin—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000197	0.00206	CbGpPWpGaD
Oxybutynin—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000197	0.00206	CbGpPWpGaD
Oxybutynin—CHRM5—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000194	0.00203	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—SDHA—dilated cardiomyopathy	0.000183	0.00192	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	0.000181	0.0019	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000179	0.00187	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000179	0.00187	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000172	0.0018	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000172	0.0018	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000171	0.00179	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	0.000171	0.00178	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00017	0.00177	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000167	0.00174	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000163	0.0017	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000163	0.0017	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000163	0.0017	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000162	0.0017	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000161	0.00169	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000161	0.00168	CbGpPWpGaD
Oxybutynin—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000159	0.00166	CbGpPWpGaD
Oxybutynin—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000158	0.00165	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	0.000157	0.00164	CbGpPWpGaD
Oxybutynin—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000157	0.00164	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	0.000154	0.00161	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000151	0.00158	CbGpPWpGaD
Oxybutynin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000149	0.00156	CbGpPWpGaD
Oxybutynin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000148	0.00155	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	0.000148	0.00154	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000147	0.00153	CbGpPWpGaD
Oxybutynin—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000145	0.00152	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000138	0.00144	CbGpPWpGaD
Oxybutynin—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000137	0.00143	CbGpPWpGaD
Oxybutynin—CHRM3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000136	0.00143	CbGpPWpGaD
Oxybutynin—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000135	0.00141	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	0.000134	0.0014	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000131	0.00137	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ANKRD1—dilated cardiomyopathy	0.000129	0.00135	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000126	0.00132	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000126	0.00132	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000126	0.00132	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000126	0.00132	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000125	0.00131	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000125	0.0013	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000125	0.0013	CbGpPWpGaD
Oxybutynin—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000124	0.0013	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—TAZ—dilated cardiomyopathy	0.000121	0.00127	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000121	0.00126	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000121	0.00126	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000119	0.00125	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000119	0.00124	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000117	0.00123	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000117	0.00122	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000116	0.00121	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000115	0.0012	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000115	0.0012	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000114	0.0012	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000114	0.0012	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000114	0.00119	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000113	0.00118	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000113	0.00118	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000113	0.00118	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000112	0.00117	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—SDHA—dilated cardiomyopathy	0.00011	0.00115	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000108	0.00113	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000107	0.00111	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000106	0.00111	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000105	0.0011	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000103	0.00108	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000103	0.00108	CbGpPWpGaD
Oxybutynin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000102	0.00107	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000102	0.00107	CbGpPWpGaD
Oxybutynin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000102	0.00106	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000102	0.00106	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	9.71e-05	0.00102	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—AGT—dilated cardiomyopathy	9.7e-05	0.00101	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	9.68e-05	0.00101	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—AGTR2—dilated cardiomyopathy	9.62e-05	0.00101	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CXCL2—dilated cardiomyopathy	9.62e-05	0.00101	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	9.59e-05	0.001	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—RAC1—dilated cardiomyopathy	9.22e-05	0.000964	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.21e-05	0.000963	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.18e-05	0.00096	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	9.09e-05	0.000951	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CXCR3—dilated cardiomyopathy	8.94e-05	0.000935	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.82e-05	0.000922	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—AGT—dilated cardiomyopathy	8.81e-05	0.000921	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.79e-05	0.000919	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	8.7e-05	0.00091	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—ADRB1—dilated cardiomyopathy	8.66e-05	0.000906	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	8.43e-05	0.000882	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.37e-05	0.000875	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.34e-05	0.000872	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	8.26e-05	0.000863	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.15e-05	0.000852	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.94e-05	0.00083	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	7.93e-05	0.000829	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.63e-05	0.000798	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.61e-05	0.000795	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	7.53e-05	0.000787	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—AGTR1—dilated cardiomyopathy	7.4e-05	0.000773	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	7.17e-05	0.00075	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.15e-05	0.000748	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.15e-05	0.000747	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.13e-05	0.000745	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	7.06e-05	0.000738	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—ADRB2—dilated cardiomyopathy	7.02e-05	0.000734	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.83e-05	0.000714	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.81e-05	0.000712	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.77e-05	0.000708	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.77e-05	0.000708	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.75e-05	0.000706	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.75e-05	0.000706	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	6.75e-05	0.000705	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	6.69e-05	0.000699	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	6.69e-05	0.000699	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.49e-05	0.000679	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.47e-05	0.000677	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	6.41e-05	0.00067	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.3e-05	0.000658	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.28e-05	0.000656	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	6.22e-05	0.00065	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	6.21e-05	0.000649	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	6.19e-05	0.000647	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	6.13e-05	0.00064	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—RAF1—dilated cardiomyopathy	6.12e-05	0.000639	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.1e-05	0.000638	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.08e-05	0.000636	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	6.03e-05	0.00063	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	6.02e-05	0.000629	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—RAC1—dilated cardiomyopathy	5.45e-05	0.00057	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.21e-05	0.000545	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—AGT—dilated cardiomyopathy	5.21e-05	0.000544	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.19e-05	0.000543	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	5.14e-05	0.000538	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	4.98e-05	0.000521	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.94e-05	0.000517	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.93e-05	0.000515	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	4.88e-05	0.00051	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—CD36—dilated cardiomyopathy	4.85e-05	0.000507	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—AGT—dilated cardiomyopathy	4.37e-05	0.000457	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.31e-05	0.00045	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.29e-05	0.000449	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	4.25e-05	0.000444	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.25e-05	0.000444	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.23e-05	0.000443	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—EGFR—dilated cardiomyopathy	4.19e-05	0.000438	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	4.19e-05	0.000438	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	4.19e-05	0.000438	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	4.08e-05	0.000427	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	3.84e-05	0.000401	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	3.82e-05	0.0004	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	3.79e-05	0.000396	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	3.67e-05	0.000384	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	3.67e-05	0.000383	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	3.65e-05	0.000382	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	3.63e-05	0.000379	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	3.62e-05	0.000378	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—RAF1—dilated cardiomyopathy	3.61e-05	0.000378	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	3.53e-05	0.00037	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	3.18e-05	0.000333	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GPX1—dilated cardiomyopathy	2.98e-05	0.000312	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.95e-05	0.000309	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.94e-05	0.000308	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	2.92e-05	0.000305	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CD36—dilated cardiomyopathy	2.9e-05	0.000303	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—AGT—dilated cardiomyopathy	2.61e-05	0.000273	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	2.54e-05	0.000266	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	2.54e-05	0.000265	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	2.51e-05	0.000263	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—EGFR—dilated cardiomyopathy	2.48e-05	0.000259	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	1.95e-05	0.000204	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	1.9e-05	0.000198	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	1.74e-05	0.000182	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	1.74e-05	0.000182	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	1.72e-05	0.00018	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.71e-05	0.000179	CbGpPWpGaD
